Archives: Search / 2019 / 2018 / 2017 / 2016 / 2015 / 2014 / 2013 / 2012 / 2011 / 2010
2019 Archives
Feb 6, 2019 - Recent 17 Product Launches Contributed $40 Million of Net Sales in Fiscal 2019 YTD Lannett Company, Inc. (NYSE: LCI) today reported financial results for its fiscal 2019 second quarter ended December 31, 2018. "Stellar sales across our product offering drove our strong fiscal... More |
Feb 6, 2019 Product Launches, Cost Savings, Insulin Glargine
|
Jan 30, 2019 Lannett Company, Inc. (NYSE: LCI) today announced that it will report financial results for its fiscal 2019 second quarter on Wednesday, February 6, 2019, after the market closes. Lannett... More |
Jan 22, 2019 Company Has Begun Marketing Entacapone IR Tablets Lannett Company, Inc. (NYSE: LCI) today announced that it has entered into an agreement with a strategic alliance partner to be the exclusive U.S. distributor of Trientine Hydrochloride Capsules,... More |
Price Data
NYSELCI